DE60030726D1 - Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material - Google Patents

Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material

Info

Publication number
DE60030726D1
DE60030726D1 DE60030726T DE60030726T DE60030726D1 DE 60030726 D1 DE60030726 D1 DE 60030726D1 DE 60030726 T DE60030726 T DE 60030726T DE 60030726 T DE60030726 T DE 60030726T DE 60030726 D1 DE60030726 D1 DE 60030726D1
Authority
DE
Germany
Prior art keywords
biological material
containing biological
microparticles containing
producing microparticles
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60030726T
Other languages
English (en)
Other versions
DE60030726T2 (de
Inventor
Arnold Hilgers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60030726D1 publication Critical patent/DE60030726D1/de
Publication of DE60030726T2 publication Critical patent/DE60030726T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE60030726T 1999-07-08 2000-07-07 Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material Expired - Lifetime DE60030726T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99113251 1999-07-08
EP99113251 1999-07-08
EP00101030 2000-01-20
EP00101030A EP1074248A1 (de) 1999-07-08 2000-01-20 Verabreichungssystem für biologisches Material
PCT/EP2000/006460 WO2001003667A1 (en) 1999-07-08 2000-07-07 Delivery system for biological material

Publications (2)

Publication Number Publication Date
DE60030726D1 true DE60030726D1 (de) 2006-10-26
DE60030726T2 DE60030726T2 (de) 2007-09-13

Family

ID=26070448

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60030726T Expired - Lifetime DE60030726T2 (de) 1999-07-08 2000-07-07 Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material

Country Status (8)

Country Link
US (1) US7008643B1 (de)
EP (2) EP1074248A1 (de)
JP (1) JP4988114B2 (de)
AT (1) ATE339186T1 (de)
AU (1) AU770296B2 (de)
CA (1) CA2375549C (de)
DE (1) DE60030726T2 (de)
WO (1) WO2001003667A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2745068T3 (es) * 2001-12-20 2020-02-27 Merck Sharp & Dohme Composiciones de SYN3 y métodos
US20060105018A1 (en) * 2004-11-17 2006-05-18 Epstein Samuel J Therapeutic driving layer for a medical device
SE0600091L (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
US8547524B2 (en) 2006-03-21 2013-10-01 Lau Consulting, Inc. Active mask variable data integral imaging system and method
PL2089554T3 (pl) 2006-11-14 2013-10-31 Aleris Aluminum Duffel Bvba Rury wielowarstwowe zawierające stop aluminium odporny na pełzanie
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181589A (en) 1979-03-06 1980-01-01 Nasa Method for separating biological cells
US4849355A (en) 1985-01-08 1989-07-18 Wong Tai Kin Method of transferring genes into cells
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
US5985354A (en) * 1995-06-07 1999-11-16 Brown University Research Foundation Preparation of multiwall polymeric microcapsules from hydrophilic polymers
FR2651680B1 (fr) * 1989-09-14 1991-12-27 Medgenix Group Sa Nouveau procede de preparation de microparticules lipidiques.
US5478564A (en) * 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
CA2019758C (en) 1990-06-25 2001-09-04 Kevin L. Firth Improved electroporation device and method
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
ES2215207T3 (es) * 1993-03-09 2004-10-01 Baxter International Inc. Microparticulas de macromoleculas y metodos de produccion.
CA2159804A1 (en) * 1993-04-08 1994-10-27 Hayden G. Coon Cell culturing method and medium
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
AU710504B2 (en) * 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system
US5789213A (en) * 1995-05-11 1998-08-04 Health Research Inc. Method and compositions for high efficiency loading, transfection and fusion of cells by electric pulses
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
EP0842657A1 (de) * 1996-11-19 1998-05-20 OctoPlus B.V. Mikrosphären zur gesteuerten Freisetzung und Verfahren zur Herstellung dieser Mikrosphären
US5989463A (en) * 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6224794B1 (en) * 1998-05-06 2001-05-01 Angiotech Pharmaceuticals, Inc. Methods for microsphere production
US6291013B1 (en) * 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles

Also Published As

Publication number Publication date
DE60030726T2 (de) 2007-09-13
EP1200067A1 (de) 2002-05-02
EP1200067B1 (de) 2006-09-13
CA2375549A1 (en) 2001-01-18
AU5983300A (en) 2001-01-30
WO2001003667A1 (en) 2001-01-18
EP1074248A1 (de) 2001-02-07
JP4988114B2 (ja) 2012-08-01
CA2375549C (en) 2008-11-25
US7008643B1 (en) 2006-03-07
JP2003504320A (ja) 2003-02-04
AU770296B2 (en) 2004-02-19
ATE339186T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
DE69717519T2 (de) Verfahren zur Herstellung von biologischem Implantationsmaterial
EP1555319A3 (de) Modifizierte Nukleinsaüresequenzen und Verfahren zur Erhöhung der mRNA-niveau und der Proteinexpression in Zellsystemen
ATE313642T1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
DE69929310D1 (de) Tumorassoziierte antigenderivate der mage-familie, nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
WO1999064592A3 (en) Green fluorescent proteins for measuring the ph of a biological sample
ATE535615T1 (de) Chemisch modifizierte nukleinsäuren und methode zur kopplung von nukleinsäuren an einen festen träger
ATE290381T1 (de) Neues verfahren zur herstellung fester dispersionen enthaltend paroxetin
DE69934242D1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
DE69121618T2 (de) Mutierte Luciferase vom Leuchtkäfer, mutiertes Luciferasegen, rekombinante DNS diese Gene enthaltend, und Verfahren zur Herstellung von mutierter Luciferase
DE69628290D1 (de) Methoden und zusammensetzungen zur lipidisierung hydrophiler moleküle
DE60002793D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
WO1999047661A3 (en) Production of biofilaments in transgenic animals
DE69935978D1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
DE60017237D1 (de) Verfahren zur mikrobiellen Herstellung von Polyestern
ATE339186T1 (de) Methode zur herstellung von mikropartikeln enthaltend biologisches material
ATE222601T1 (de) Methode zur expression in und isolation von biologisch aktiven molekülen aus urin
DE60020048D1 (de) Verfahren zur Herstellung von Methacrylsäure
DE60038565D1 (de) Verfahren zur herstellung von ubiquinon-10
ATE364690T1 (de) Posh nukleinsäure, polypeptide und darauf bezogene verfahren
DE60010034D1 (de) Methode zur handhabung von 1,1,1,3,3-pentfluoropropan
DE60136558D1 (de) Verfahren zur kultivierung humaner chondrozyten
DE69708682T2 (de) Methode zur herstellung von zusammengesetztem keramischen material
DE60236511D1 (de) Biosynthetische gene zur herstellung von butenyl-spinosyn-haltigem insektizid
DE69842119D1 (de) Methode zur herstellung von canine interleukin 18
ATE297884T1 (de) Verfahren zur herstellung von 2-(4-(2,2,- dihalocyclopropyl)phenoxy)-alkansäuren und ihre estern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition